NEWS
Symrise in double Asian expansion
Symrise has announced that it has opened its new Scent Creative Centre in Singapore and is investing in additional production capacity for the fragrance ingredient Globalide in India( pictured). The amounts involved were not disclosed but the company said that both support its‘ ONE Symrise’ strategy.
The Scent Creative Centre will combine the capabilities of multiple businesses within the company to translate fragrances into products. It uses settings that mirror real-life places where they are used, such as a bathroom for skin cleansing facilities and a salon for hair care products.
This is part of multi-phase investment in Singapore, where Symrise has already spent € 80 million in capabilities spanning neuroscience, AI and automation over the past ten years. In Q1 2027, the company will add an innovation centre adjacent to the new centre to expand its analytical and research capabilities for co-creation with customers and universities.
Singapore is also already home to Symrise’ s new Global Skin Cleansing Centre of Excellence, which supports the development of bar soaps, shower gels, handwash and emerging cleansing formats of all kinds.
Globalide, meanwhile, is a biodegradable macrocyclic musk ingredient, which is said to add“ long-lasting, elegant notes to fragrances”, while combining strong olfactory performance with versatility across applications. A growing proportion of the customer base for this is also in Asia.
IN BRIEF
APG expansion opened BASF has inaugurated an expansion alkyl polyglucosides( APGs) capacity at Cincinnati, Ohio, as announced in 2023. APGs are biobased, readily biodegradable, mild, non-ionic surfactants derived from 100 % natural and renewable feedstocks for use in multiple end uses. BASF also makes them in Germany, China and Thailand.
Aarti in ten-year deal Aarti Industries has signed a longterm manufacturing and supply agreement with an unnamed global speciality chemical company that will be worth about $ 155 million over ten years. As part of this, it will set up, commission and operate a dedicated facility in India for a speciality chemical“ used in high-performance applications” which is expected to begin in 2028-9.
Curia to scale NCT process ExoZymes, which develops AI-enhanced enzymes that transform abundant feedstock into nutraceuticals and novel medicines, will transfer its proprietary manufacturing process for N-transcaffeoyltyramine( NCT) for scaling at Curia’ s sites in León, Spain, and Rozzano, Italy. Los Angelesbased ExoZymes described this as“ the next major step” from pilot-scale validation toward commercial manufacturing.
Holiferm, Organica to merge Holiferm, a University of Manchester spin-out that makes naturally derived biosurfactants, and Organica UK, a supplier of biodegradable and non-hazardous household laundry and cleaning products, are to merge, with continuing financial backing from investor Sadorp. The companies have been based at adjacent sites in Wallasey, near Liverpool, since 2023.
NOV / DEC 2026 SPECCHEMONLINE. COM
11